Health Care & Life Sciences » Healthcare Provision | Burzynski Research Institute Inc.

Burzynski Research Institute Inc. | Income Statement

Fiscal year is March-February. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Cost of Goods Sold (COGS) incl. D&A
0.70
0.70
0.70
0.70
-
-
Gross Income
0.70
0.70
0.70
0.70
-
-
SG&A Expense
4,271.10
2,891.40
2,004.40
1,504.00
1,613.10
1,637.70
EBIT
4,271.80
2,892.10
2,005.10
1,504.70
1,613.10
1,637.70
Non Operating Income/Expense
-
0.10
-
-
1.00
-
Pretax Income
4,271.80
2,892.00
2,005.10
1,504.70
1,612.10
1,637.70
Consolidated Net Income
4,271.80
2,892.00
2,005.10
1,504.70
1,612.10
1,637.70
Net Income
4,271.80
2,892.00
2,005.10
1,504.70
1,612.10
1,637.70
Net Income After Extraordinaries
4,271.80
2,892.00
2,005.10
1,504.70
1,612.10
1,637.70
Net Income Available to Common
4,271.80
2,892.00
2,005.10
1,504.70
1,612.10
1,637.70
EPS (Basic)
0.03
0.02
0.02
0.01
0.01
0.01
Basic Shares Outstanding
131,448.40
131,448.40
131,448.40
131,448.40
131,448.40
131,448.40
EPS (Diluted)
0.03
0.02
0.02
0.01
0.01
0.01
Diluted Shares Outstanding
131,448.40
131,448.40
131,448.40
131,448.40
131,448.40
131,448.40
EBITDA
4,271.10
2,891.40
2,004.40
1,504.00
1,613.10
1,637.70

About Burzynski Research Institute

View Profile
Address
9432 Katy Freeway
Houston Texas 77055
United States
Employees -
Website http://www.burzynskiresearch.com
Updated 07/08/2019
Burzynski Research Institute, Inc. engages in the research and development facility for Antineoplaston drugs being tested for the use in the treatment of cancer. The company was founded by Stanislaw R. Burzynski in 1984 and is headquartered in Houston, TX.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.